What we know and what we think we know: An editor's perspective on a charged debate

Author： Khuri Fadlo R.  

Publisher： Blackwell Publishing

E-ISSN： 1097-0142|121|1|4-5

ISSN： 0008-543X

Source： Cancer, Vol.121, Iss.1, 2015-01, pp. : 4-5

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

Idarucizumab: What Should We Know?

By  

Current Drug Targets, Vol. 19, Iss. 1, 2018-01 ,pp. : 81-88

Bentham Science Publishers

Access to resources Recommend Favorite

Assays and applications in warfarin metabolism: what we know, how we know it and what we need to know

By Jones Drew R   Miller Grover P  

Expert Opinion on Drug Metabolism and Toxicology, Vol. 7, Iss. 7, 2011-07 ,pp. : 857-874

Informa Healthcare

Access to resources Recommend Favorite

Adenosine Receptors: What We Know and What We are Learning

By  

Current Topics in Medicinal Chemistry, Vol. 10, Iss. 9, 2010-06 ,pp. : 860-877

Bentham Science Publishers

Access to resources Recommend Favorite

WHAT WE KNOW AND WHAT WE NEED TO KNOW ABOUT DEVELOPMENTAL ALUMINUM TOXICITY

By Golub Mari S.   Domingo Jose L.  

Journal of Toxicology and Environmental Health, Vol. 48, Iss. 6, 1996-08 ,pp. : 585-598

Taylor & Francis Ltd

Access to resources Recommend Favorite

Physical Activity and Alcohol Use Disorders: What We Know and What We Don't Know

By Vingren Jakob L.  

The American Journal of Drug and Alcohol Abuse, Vol. 39, Iss. 2, 2013-03 ,pp. : 69-71

Informa Healthcare

Access to resources Recommend Favorite